Skip to content

Capri Holdings CPRI Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Accessories55.8%+0.7%
Footwear24.6%+0.4%
Apparel12.8%-4.5%

Other financials

Income statement

See full
Revenue$796.0M-3.7%
Gross profit$516.0M+4.2%
Operating income$46.0M+76.9%
Net income-+100%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$135.0M+26.2%
Total debt$1.4B-54.1%
Total equity$80.0M-78.3%
Total assets$3.2B-38.0%

Cash flow

See full
Operating cash flow$202.0M-34.6%
CapEx$18.0M+12.5%
Free cash flow$183.0M-36.2%

Valuation

See full
Market cap$2.17B+11.6%
Enterprise value$3.45B-23.5%
P/E15.4×
P/S0.6×+0.1×

Profitability

See full
Gross margin62.3%+0.1pp
Operating margin-0.2%
Net margin4.1%+2.1pp
FCF margin14.5%+10.2pp

Returns & leverage

See full
Return on equity62.9%+38.0pp
Debt / equity17.8×+9.3×
Current ratio1.2×+0.1×